Brief: Rafael Holdings Strengthens its Focus on the Development of Trappsol Cyclo and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role
April 24 (Reuters) - Rafael Holdings Inc RFL.N: RAFAEL HOLDINGS STRENGTHENS ITS FOCUS ON THE DEVELOPMENT OF TRAPPSOL® CYCLO™ AND ANNOUNCES CHIEF EXECUTIVE OFFICER BILL CONKLING WILL BE STEPPING DOWN FROM HIS ROLE RAFAEL HOLDINGS INC - HOWARD JONAS TO ASSUME ROLE OF CEO AT RAFAEL HOLDINGS Source text: ID:nGNX6Bv6Kc Further company coverage: RFL.N ((Reuters.Briefs@thomsonreuters.com))
Recent news on Rafael Holdings
See all newsBrief: Rafael Holdings Announces Topline Results From The Pivotal Phase 3 Transportnpc™ Study Of Trappsol® Cyclo™ In Niemann-Pick Disease Type C (Npc)
Israel expects new air defence orders from Europe due to Russia concerns
Biotech firm Rafael's Q3 net loss narrows; set to submit NDA for Trappsol Cyclo in H2
Rafael Holdings Q2 net loss widens on consolidation of Cyclo Therapeutic's costs
Brief: Rafael Holdings Q2 Net Income USD -6.327 Million